Advances in Human Biology: Combining Genetics and Molecular Biophysics to Pave the Way for Personalized Diagnostics and Medicine

Keywords

Pharmacogenomics, Personalized medicine, Genomics, Computational biology, Human genome

References

• Evaluation of Methods for De Novo Genome Assembly from High-Throughput Sequencing Reads Reveals Dependencies That Affect the Quality of the ResultsF. Mougel, S. Chabroux, Pierre Mathieu — 2011
• Structural Analysis of SHARPIN, a Subunit of a Large Multi-protein E3 Ubiquitin Ligase, Reveals a Novel Dimerization Function for the Pleckstrin Homology SuperfoldBenjamin Stieglitz, L.F. Haire, Ivan Đikić — 2012
• In silico study on the inhibitory interaction of drugs with wild-type CYP2D6.1 and the natural variant CYP2D6.17.Koichi Handa, Izumi Nakagome, Noriyuki Yamaotsu — 2014
• Methods for identifying and studying genetic alterations in hormone-dependent cancers.Outi R. Saramäki, Kati K. Waltering, Tapio Visakorpi — 2009
• Evaluation of the sequence template method for protein structure prediction. Discrimination of the (beta/alpha)8-barrel fold.Stephen D. Pickett, Mansoor Saqi, Michael J.E. Sternberg — 1992
• Race as a proxy for drug response: the dangers and challenges of ethnic drugs.René Bowser — 2004
• Predicting protein-DNA interactions by full search computational dockingVictoria A. Roberts, Michael E. Pique, Lynn F. Ten Eyck — 2013
• Creating a structural genomics consortiumAlan R. Williamson — 2000
• Enhancing Human Spermine Synthase Activity by Engineered MutationsZhe Zhang, Yueli Zheng, Margo Petukh — 2013
• Searching NCBI’s dbSNP databaseMedha Bhagwat — 2010
• Discriminative topological features reveal biological network mechanismsManuel Middendorf, Etay Ziv, Carter Adams — 2004
• CGMIM: Automated text-mining of Online Mendelian Inheritance in Man (OMIM) to identify genetically-associated cancers and candidate genesChris Bajdik, Byron Kuo, Shawn Rusaw — 2005
• A novel p.Leu(381)Phe mutation in Presenilin 1 is associated with very early onset and unusually fast progressing dementia, and lysosomal inclusions typically seen in Kufs diseaseNatalia Dolzhanskaya, Michael Gonzalez, Fiorella Sperziani — 2014
• Research and applications: A rational free energy-based approach to understanding and targeting disease-causing missense mutationsZhe Zhang, Shawn Witham, Marharita Petukh — 2013
• Beryllium disease among construction trade workers at Department of Energy nuclear sites.Laura S. Welch, Knut Ringen, John M. Dement — 2013
• Predicting free energy changes using structural ensemblesA Benedix, Caroline M Becker, Bert L. de Groot — 2009
• Protein–protein docking using 3D‐Dock in rounds 3, 4, and 5 of CAPRIPhil Carter, Victor I. Lesk, Suhail A. Islam — 2005
• Raising money for cystic fibrosis: At what price?Anton R. Miller — 2010
• The 1000 Genomes Project: Data Management and Community AccessLaura Clarke, Xiangqun Zheng-Bradley, Richard Smith — 2012
• A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants.E. R. Park, Joanna M. Streck, Ilana F. Gareen — 2014

Cited by

• Investigating the linkage between disease-causing amino acid variants and their effect on protein stability and bindingYunhui Peng, Emil Alexov — 2016
• Personalized Biochemistry and BiophysicsBrett M. Kroncke, Carlos G. Vanoye, Jens Meiler — 2015
• Structural and Physico-Chemical Effects of Disease and Non-Disease nsSNPs on ProteinsTugba G. Kucukkal, Marharyta Petukh, Lin Li — 2015
• Induced structural disorder as a molecular mechanism for enzyme dysfunction in phosphoglucomutase 1 deficiencyKyle M. Stiers, Bailee Kain, Abigail C. Graham — 2016
• Molecular Dynamics: New Frontier in Personalized Medicine.P. Sneha, C. George Priya Doss — 2016
• Genetic Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in the Arab WorldC. George Priya Doss, Dima R. Alasmar, Reem Ibrahim Bux — 2016
• Structural Perspective on Revealing and Altering Molecular Functions of Genetic Variants Linked with DiseasesYunhui Peng, Emil Alexov, Sankar Basu — 2019
• Precision medicine review: rare driver mutations and their biophysical classificationRuth Nussinov, Hyunbum Jang, Chung‐Jung Tsai — 2019
• Modelling the Effects of Disease-Associated Single Amino Acid Variants and Rescuing the Effects by Small MoleculesYunhui Peng — 2018
• Autoinhibition can identify rare driver mutations and advise pharmacologyRuth Nussinov, Chung‐Jung Tsai, Hyunbum Jang — 2020
• Structural Perspective on Revealing and Altering Molecular Mechanisms of Genetic Variants Linked with DiseasesYunhui Peng, Emil Alexov, Sankar Basu — 2018
• Pan-cancer clinical impact of latent drivers from double mutationsBengi Ruken Yavuz, Chung‐Jung Tsai, Ruth Nussinov — 2023
• Review on Human Reference and Personal Genome Big Data AnalysisBalamurugan Sivaprakasam, Jothimalar Ramalingam — 2017
• Genetic Epidemiology of Glucose-6-Dehydrogenase Deficiency in the Arab WorldC. George, Priya Doss, Dima R. Alasmar — 2016

Related papers

• IMPACT OF PHARMACOGENOMICS ON PERSONALIZED MEDICINE: A COMPREHENSIVE REVIEWEyad ahmed althagafi, Fahad Rajaallah Almutairi, Dalia zaki baik — 2022
• Pharmacogenomics and personalized medicinesLiu Gen-yuan — 2007
• Translating pharmacogenomics into personalized medicine and drug development.Wei Zhang, Thomas Y.K. Chan, Lan Fan — 2012
• Practical Challenges and Translational Issues in Pharmacogenomics and Personalized Medicine from 2010 OnwardsLaith N. AL‐Eitan, Amneh H. Tarkhan — 2017
• Critical appraisal of the views of healthcare professionals with respect to pharmacogenomics and personalized medicine in Greece.Yuan Mai, Christina Mitropoulou, Xanthi E Papadopoulou — 2014
• Pharmacogenomic biomarkers for personalized medicine.James J. Chen, Wei‐Jiun Lin, Hung-Chia Chen — 2013
• Pharmacogenomics: A Step forward Precision Medicine in Childhood AsthmaGiuliana Ferrante, Salvatore Fasola, Velia Malizia — 2022
• Precision Medicine: Pharmacogenomics and Breast CancerJ. Shuman, J. N. Ingle — 2015